Search

Search Results

• Introducing “HEDGE”: sequential intravesical gemcitabine-based thermochemotherapy (HIVEC) plus docetaxel as a potential novel bladder-sparing strategy for BCG-unresponsive non-muscle-invasive bladder cancer

  Lampros Mitrakas, Athanasios Zisopoulos, Konstantinos Dimitropoulos, Spyridon Siafakas, Krystallia Gkouletsa, Vassilios Tzortzis

  09-09-2026

  https://doi.org/10.4081/aiua.2026.15738

  9

  Downloads: 3
• 

  Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

  Gianpaolo Perletti, Elena Monti, Emanuela Marras, Anne Cleves, Vittorio Magri, Alberto Trinchieri, Paul S. Rennie

  121-129

  07-07-2015

  https://doi.org/10.4081/aiua.2015.2.121

  11262

  Downloads: 6067

• A national perspective on the management of high-risk BCG-unresponsive non-muscle-invasive bladder cancer in Romania

  Maximilian Buzoianu, Bogdan Adrian Buhas, Mohamad Abou Chakra, Emanuela Ionutas, Mihnea Bogdan Borz, Nicolae Crisan, Michael A O'Donnell

  24-12-2025

  https://doi.org/10.4081/aiua.2025.14596

  864

  Downloads: 491

• Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists

  Mohamad Moussa, Mohamad Abou Chakra, Neal D. Shore, Athanasios Papatsoris, Yasser Farahat, Michael A. O’Donnell

  19-03-2024

  https://doi.org/10.4081/aiua.2024.12244

  2143

  Downloads: 4517

• Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study

  Ana Marta Ferreira, André Rego, Vasco Quaresma, Roberto Jarimba, Edgar Tavares da Silva, Pedro Nunes, Arnaldo Figueiredo

  07-08-2026

  https://doi.org/10.4081/aiua.2026.15630

  119

  Downloads: 78
• 

  A case with primary signet ring cell adenocarcinoma of the prostate and review of the literature

  Orcun Celik, Salih Budak, Gokhan Ekin, Ilker Akarken, Yusuf Ozlem Ilbey

  148-149

  30-06-2014

  https://doi.org/10.4081/aiua.2014.2.148

  3271

  Downloads: 1606
• 

  Prostate-specific antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

  Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho

  22-02-2023

  https://doi.org/10.4081/aiua.2023.11052

  1399

  Downloads: 1129
• 

  C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer

  João Lorigo, Edgar Tavares Silva, João Pedroso Lima, Vasco Quaresma, Rui Pedrosa, Arnaldo Figueiredo

  11-07-2023

  https://doi.org/10.4081/aiua.2023.11242

  1333

  Downloads: 720

• Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

  Ana Marta Ferreira, Tiago Sousa, Roberto Jarimba, Vasco Quaresma, Pedro Nunes, Edgar Tavares da Silva, Arnaldo Figueiredo

  03-11-2025

  https://doi.org/10.4081/aiua.2025.14179

  1004

  Downloads: 568